Page last updated: 2024-08-21

thiazoles and Adenoma, Prostatic

thiazoles has been researched along with Adenoma, Prostatic in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19902 (7.69)18.7374
1990's0 (0.00)18.2507
2000's2 (7.69)29.6817
2010's9 (34.62)24.3611
2020's13 (50.00)2.80

Authors

AuthorsStudies
Almgren-Rachtan, A; Chudek, J; Olszanecka-Glinianowicz, M; Owczarek, AJ; Zdrojowy, R1
El-Assmy, A; Elbaz, R; Hashem, A; Shokeir, AA; Zahran, MH1
Cambronero Santos, J; Chapple, C; Choudhury, N; Foley, S; Hairston, J; Herschorn, S; Kaplan, SA; Kristy, RM; McVary, KT; Schermer, CR; Staskin, D1
Fuse, M; Kaga, K; Kageyama, S; Sakata, K; Tokunaga, S; Yamanishi, T; Yokoyama, T1
Chen, Z; Gao, Y; Liang, L; Lin, J; Liu, L; Su, S1
Peyronnet, B1
Chen, CH; Chuang, YC; Lee, WC; Shen, YC; Wang, HJ1
Kwon, SY; Lee, KS; Park, DJ; Seo, YJ1
Kato, D; Tabuchi, H; Takahashi, S; Uno, S1
El-Abd, AS; El-Abd, SA; Radwan, MH; Soliman, MG; Tawfik, AM1
Cambronero Santos, J; Choudhury, N; Foley, S; Hairston, J; Herschorn, S; Kaplan, SA; Kristy, RM; McVary, KT1
Kaplan, SA; Mullen, GR1
Behera, DP; Gupta, S; Singh, I; T K, A1
Funahashi, Y; Gotoh, M; Kato, M; Majima, T; Matsukawa, Y; Sassa, N; Takai, S; Yamamoto, T1
Dmochowski, R; Kaufman, M; Osborn, D; Reynolds, WS; Suarez, O1
Fukuta, F; Ichihara, K; Iwasawa, A; Masumori, N; Tanaka, Y; Tsukamoto, T1
Guh, JH; Hsu, JL; Hsu, JT; Kudryavtsev, KV; Liu, SP; Yu, CC1
Hagiwara, M; Hasegawa, M; Ishioka, K; Kikuchi, E; Maeda, T; Miyajima, A; Miyazaki, Y; Oya, M; Shinojima, T1
Griebling, TL1
Kato, D; Kuroishi, K; Nozawa, Y; Tabuchi, H1
Kosaka, T; Kuwahara, Y; Mishima, J; Nakamura, K; Otsuki, H; Tsukamoto, T1
Abi-Chaker, A; Block, NL; Halmos, G; Jaszberenyi, M; Jayakumar, AR; Krishan, A; Perez, R; Rick, FG; Schally, AV; Shamaladevi, N; Szalontay, L; Szepeshazi, K; Vidaurre, I1
TRUINI, F1
Bonina, F; De Pasquale, A; Pennisi, C; Saija, A; Tita, B; Tomaino, A; Vitali, F1
Schulman, CC; Simon, J1

Reviews

2 review(s) available for thiazoles and Adenoma, Prostatic

ArticleYear
The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: A systematic review and meta-analysis.
    Medicine, 2020, Volume: 99, Issue:4

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Humans; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2020
Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia.
    Current urology reports, 2021, Jan-07, Volume: 22, Issue:1

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2021

Trials

9 trial(s) available for thiazoles and Adenoma, Prostatic

ArticleYear
Mirabegron for treatment of erectile dysfunction concomitant with lower urinary tract symptoms in patients with benign prostatic obstruction: A randomized controlled trial.
    International journal of urology : official journal of the Japanese Urological Association, 2022, Volume: 29, Issue:5

    Topics: Acetanilides; Doxazosin; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Thiazoles; Tolterodine Tartrate; Treatment Outcome

2022
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
    The Journal of urology, 2020, Volume: 203, Issue:6

    Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2020
A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study).
    Neurourology and urodynamics, 2020, Volume: 39, Issue:2

    Topics: Acetanilides; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents

2020
Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO.
    World journal of urology, 2021, Volume: 39, Issue:6

    Topics: Acetanilides; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Solifenacin Succinate; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2021
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study.
    Urology, 2021, Volume: 147

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Double-Blind Method; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Urinary Bladder, Overactive

2021
Efficacy and safety of tamsulosin vs its combination with mirabegron in the management of lower urinary tract non-neurogenic overactive bladder symptoms (OABS) because of Benign Prostatic Enlargement (BPE)-An open label randomised controlled clinical stud
    International journal of clinical practice, 2021, Volume: 75, Issue:7

    Topics: Acetanilides; Drug Therapy, Combination; Humans; Male; Prostatic Hyperplasia; Quality of Life; Tamsulosin; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2021
Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies.
    Neurourology and urodynamics, 2019, Volume: 38, Issue:3

    Topics: Acetanilides; Aged; Aged, 80 and over; Benzhydryl Compounds; Drug Therapy, Combination; Humans; Indoles; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents

2019
A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction.
    The Journal of urology, 2015, Volume: 193, Issue:3

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Aged; Drug Therapy, Combination; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Thiazoles; Urinary Bladder, Overactive

2015
β3-Adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men.
    International urology and nephrology, 2013, Volume: 45, Issue:1

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Female; Humans; Male; Muscarinic Antagonists; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Thiazoles; Ultrasonography; Urinary Bladder, Overactive; Urodynamics

2013

Other Studies

15 other study(ies) available for thiazoles and Adenoma, Prostatic

ArticleYear
Pharmacotherapy of patients with benign prostate enlargement and storage symptoms in everyday clinical practice.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:16

    Topics: Acetanilides; Adrenergic alpha-Antagonists; Adrenergic beta-3 Receptor Agonists; Age Factors; Aged; Cohort Studies; Decision Trees; Guideline Adherence; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Thiazoles

2021
Editorial Comment.
    The Journal of urology, 2020, Volume: 203, Issue:6

    Topics: Acetanilides; Humans; Male; Prostatic Hyperplasia; Tamsulosin; Thiazoles; Urinary Bladder, Overactive

2020
Intravesical prostatic protrusion does not compromise the therapeutic effects of Mirabegron in male patients with overactive bladder.
    International journal of clinical practice, 2020, Volume: 74, Issue:9

    Topics: Acetanilides; Aged; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2020
Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study.
    Investigative and clinical urology, 2020, Volume: 61, Issue:4

    Topics: Acetanilides; Adrenergic alpha-Antagonists; Adrenergic beta-3 Receptor Agonists; Aged; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2020
Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post-marketing study.
    Lower urinary tract symptoms, 2021, Volume: 13, Issue:1

    Topics: Acetanilides; Aged; Female; Humans; Male; Prostatic Hyperplasia; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents

2021
Mirabegron for male lower urinary tract symptoms.
    Current urology reports, 2013, Volume: 14, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Humans; Lower Urinary Tract Symptoms; Male; Nocturia; Prostatic Hyperplasia; Prostatism; Thiazoles; Urinary Bladder, Overactive; Urological Agents

2013
KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity.
    Journal of biomedical science, 2015, Jan-07, Volume: 22

    Topics: Antineoplastic Agents; Apoptosis; Aurora Kinase A; Cell Cycle; Cell Line; Humans; Male; Polymerization; Prostatic Hyperplasia; Prostatic Neoplasms; Thiazoles; Tubulin; Tubulin Modulators

2015
Solifenacin or mirabegron could improve persistent overactive bladder symptoms after dutasteride treatment in patients with benign prostatic hyperplasia.
    Urology, 2015, Volume: 85, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Aged, 80 and over; Azasteroids; Dutasteride; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Prostatic Hyperplasia; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiazoles; Urinary Bladder, Overactive

2015
Re: The Efficacy of Mirabegron Additional Therapy for Lower Urinary Tract Symptoms after Treatment with Α1-Adrenergic Receptor Blocker Monotherapy: Prospective Analysis of Elderly Men.
    The Journal of urology, 2016, Volume: 196, Issue:6

    Topics: Acetanilides; Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Receptors, Adrenergic; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive

2016
Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study.
    Lower urinary tract symptoms, 2018, Volume: 10, Issue:2

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Diabetes Complications; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention; Urological Agents

2018
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Feb-12, Volume: 110, Issue:7

    Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Bombesin; Cell Line; Cell Proliferation; Cell Size; Cyclooxygenase 2; Dose-Response Relationship, Drug; Gastrin-Releasing Peptide; Gene Expression Profiling; Humans; Male; NF-kappa B; Peptide Fragments; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Tetrazolium Salts; Thiazoles

2013
Dutasteride (Avodart) for benign prostatic hyperplasia.
    The Medical letter on drugs and therapeutics, 2002, Dec-23, Volume: 44, Issue:1146

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Azasteroids; Biological Availability; Clinical Trials as Topic; Drug Combinations; Dutasteride; Finasteride; Humans; Male; Metformin; Prostatic Hyperplasia; Thiazoles

2002
[EVALUATION OF THE THERAPEUTIC EFFECTIVENESS OF 2-ACETAMIDO-4-(5-NITRO-2FURYL)-THIAZOLE. CLINICAL CASES].
    Minerva medica, 1963, Aug-29, Volume: 54

    Topics: Epididymitis; Humans; Male; Nitrofurans; Orchitis; Postoperative Complications; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Sepsis; Thiazoles; Thrombophlebitis; Urinary Bladder Neoplasms; Urinary Tract Infections

1963
Effect of a standardized extract of red orange juice on proliferation of human prostate cells in vitro.
    Fitoterapia, 2006, Volume: 77, Issue:3

    Topics: Animals; Artemia; Biological Assay; Cell Line; Cell Proliferation; Citrus sinensis; Cricetinae; Cricetulus; Epithelial Cells; Fibroblasts; Humans; Male; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Tetrazolium Salts; Thiazoles; Trypan Blue

2006
[Treatment of inflammatory disease of the prostate with non-steroid anti-inflammatory agents].
    Acta urologica Belgica, 1983, Volume: 51, Issue:4

    Topics: Acetates; Anti-Inflammatory Agents; Humans; Male; Prostatic Hyperplasia; Prostatitis; Thiazoles

1983